A Lancet article claiming hydroxychloroquine increases the risk of death and heart problems among Covid-19 patients has been retracted. A now-retracted study warning of the dangers of the use of hydroxychloroquine on Covid-19 patients has angered researchers studying the potential benefits of the malaria drug. FDA said in April it's 'aware of reports of serious heart rhythm problems' in Covid-19 patients treated with the drug. One of these studies, the Australasian Covid-19 Trial (ASCOT), funded by the Health Research Council (HRC), involves trialling unproven treatments for the coronavirus, including hydroxychloroquine. "With funding for these trials, [New Zealand] researchers will be ready and prepared (this being a critical step) to conduct randomised clinical trials in the event of a future outbreak."
Source: Stuff June 05, 2020 10:18 UTC